0001662244-18-000002.txt : 20180516 0001662244-18-000002.hdr.sgml : 20180516 20180516121729 ACCESSION NUMBER: 0001662244-18-000002 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20180516 DATE AS OF CHANGE: 20180516 EFFECTIVENESS DATE: 20180516 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Cyteir Therapeutics, Inc. CENTRAL INDEX KEY: 0001662244 IRS NUMBER: 455429901 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-308831 FILM NUMBER: 18839376 BUSINESS ADDRESS: STREET 1: 763E CONCORD AVENUE CITY: CAMBRIDGE STATE: MA ZIP: 02138 BUSINESS PHONE: 617-248-5239 MAIL ADDRESS: STREET 1: 763E CONCORD AVENUE CITY: CAMBRIDGE STATE: MA ZIP: 02138 D/A 1 primary_doc.xml X0708 D/A LIVE 0001662244 Cyteir Therapeutics, Inc. 763E CONCORD AVENUE CAMBRIDGE MA MASSACHUSETTS 02138 617-248-5239 DELAWARE None None Corporation true Ronald Goldstein c/o Cyteir Therapeutics, Inc. 763E Concord Avenue Cambridge MA MASSACHUSETTS 02138 Executive Officer Timothy Romberger c/o Cyteir Therapeutics, Inc. 763E Concord Avenue Cambridge MA MASSACHUSETTS 02138 Executive Officer Director Markus Renschler c/o Cyteir Therapeutics, Inc. 763E Concord Avenue Cambridge MA MASSACHUSETTS 02138 Executive Officer Director Racquel Bracken c/o Cyteir Therapeutics, Inc. 763E Concord Avenue Cambridge MA MASSACHUSETTS 02138 Director Bart Van Hooland c/o Cyteir Therapeutics, Inc. 763E Concord Avenue Cambridge MA MASSACHUSETTS 02138 Director Jean George c/o Cyteir Therapeutics, Inc. 763E Concord Avenue Cambridge MA MASSACHUSETTS 02138 Director Biotechnology Decline to Disclose 06b true 0001662244-18-000001 2018-01-03 false true false 0 MTS Securities, LLC 104059 None None 623 Fifth Avenue, 14th Floor New York NY NEW YORK 10022 NY NEW YORK CA CALIFORNIA PA PENNSYLVANIA false 35000000 5833326 29166674 false 12 1360000 true 0 Subject to future issuances. 0 false Cyteir Therapeutics, Inc. /s/ Markus Renschler Markus Renschler President and CEO 2018-05-16